 ROSELAND, N.J., Dec. 16, 2020 GLOBE NEWSWIRE -- Milestone Scientific Inc. NYSE American:MLSS, a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today reported that the Companys Interim CEO, Leonard Osser, plans to exercise up to 336,970 options. In connection with the transaction, he plans to sell a portion of his shares to cover the cost of the options and associated taxes. However, the net impact of the transaction will be an increase in Mr. Ossers overall common stock holdings. Mr. Osser has no plans to sell additional shares. 